Adam Havey has sold EBS and made no open-market buys since Mar 2016

EVP, Business Operations at Emergent BioSolutions Inc.

SEC CIK 0001514588 · Filings on SEC.gov ↗

$0Bought

$11.0MSold

NoneLast buy

Every filing

15 filings since Mar 2016, newest first

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$3.7M−49.0%Mar 3

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$2.5M−52.0%Apr 21

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$478K−19.0%Apr 8

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$138K−7.0%Mar 13

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$177K−8.0%Mar 4

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$526K−22.0%Nov 5

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$1.4M−44.0%Oct 17

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$309K−16.0%Mar 13

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$94K−5.0%Mar 1

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$311K−23.0%Sep 29

EBSSell

Emergent Biosolutions Inc.

EVP, Business Operations

$292K−23.0%Sep 12

EBSSell

Emergent Biosolutions Inc.

EVP, Biodefense Divison

$327K−30.0%Apr 4

EBSSell

Emergent Biosolutions Inc.

EVP, Biodefense Divison

$251K−20.0%Jan 19

EBSSell

Emergent Biosolutions Inc.

EVP, Biodefense Divison

$148K−10.0%Mar 16

EBSSell

Emergent Biosolutions Inc.

EVP, Biodefense Divison

$376K−21.0%Mar 15

Filings come from SEC EDGAR. Not investment advice.